Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension

Hidenao Kayawake, Satona Tanaka, Yoshito Yamada, Shiro Baba, Hideyuki Kinoshita, Kazuhiro Yamazaki, Tadashi Ikeda, Kenji Minatoya, Yojiro Yutaka, Masatsugu Hamaji, Akihiro Ohsumi, Daisuke Nakajima, Hiroshi DateKyoto University. Kobe City Medical Center General Hospital.Japan European Journal of Cardiothoracic SurgeryEur J Cardiothorac Surg 2023; DOI: 10.1093/ejcts/ezad024 AbstractObjectives: Living-donor lobar lung transplantation (LDLLT) is a life-saving procedure for critically ill […]

Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension Read More »

Pulmonary hypertension due to high cardiac output

Kanza N. Qaiser, Sandeep Sahay, Arriano R. TonelliCleveland Clinic. Houston Methodist Hospital.United States Respiratory MedicineRespir Med 2023; DOI: 10.1016/j.rmed.2022.107034 AbstractPulmonary hypertension (PH) is usually associated with a normal or decreased cardiac output (CO). Less commonly, PH can occur in the context of a hyperdynamic circulation, characterized by high CO (>8 L/min) and/or cardiac index ≥4 L/min/m2 in

Pulmonary hypertension due to high cardiac output Read More »

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants

David Montani, Benoit Lechartier, Barbara Girerd, Mélanie Eyries, Maria-Rosa Ghigna, Laurent Savale, Xavier Jaïs, Andrei Seferian, Mitja Jevnikar, Athénais Boucly, Marianne Riou, Julie Traclet, Ari Chaouat, Maryline Levy, Jerome LePavec, Elie Fadel, Frédéric Perros, Florent Soubrier, Martine Remy-Jardin, Olivier Sitbon, Damien Bonnet, Marc HumbertHôpitaux de Paris, Université Paris-Saclay, Hôpital Marie Lannelongue, Hôpital Pitié-Salpêtrière, Nouvel Hôpital

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants Read More »

Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review

Chantal Lokhorst, Sjoukje van der Werf, Rolf M. F. Berger, Johannes M. DouwesUniversity of Groningen, Beatrix Children’s Hospital and University Medical Center GroningenNetherlands Frontiers in Cardiovascular MedicineFront Cardiovasc Med 2022; 9: 1035453DOI: 10.3389/fcvm.2022.1035453 AbstractIntroduction: Currently, risk stratification is the cornerstone of determining treatment strategy for patients with pulmonary arterial hypertension (PAH). Since the 2015 European Society of

Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review Read More »

Correlation between Pulmonary Artery Pressure and Vortex Duration Determined by 4D Flow MRI in Main Pulmonary Artery in Patients with Suspicion of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Jean-Francois Deux, Lindsey A. Crowe, Leon Genecand, Anne-Lise Hachulla, Carl G. Glessgen, Stephane Noble, Maurice Beghetti, Jin Ning, Daniel Giese, Frederic Lador, Jean-Paul ValleeGeneva University Hospital. University of Geneva. Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique. Siemens Medical Solutions. Siemens Healthcare GmbHSwitzerland, United States and Germany Journal of Clinical MedicineJ Clin Med 2022;

Correlation between Pulmonary Artery Pressure and Vortex Duration Determined by 4D Flow MRI in Main Pulmonary Artery in Patients with Suspicion of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Read More »

Randomized, controlled study of inhaled nitric oxide following surgery for congenital heart disease

Ronald W. Day, John A. Hawkins, Edwin C. McGough, Kevin L. Crezee, Garth S. OrsmondUniversity of Utah and Primary Children’s HospitalUnited States Annals of Thoracic SurgeryAnn Thorac Surg 2000; 69: 1907-1913DOI: 10.1016/s0003-4975(00)01312-6 AbstractBackground: Inhaled nitric oxide selectively decreases pulmonary vascular resistance. This study was performed to determine whether inhaled nitric oxide decreases the incidence of pulmonary hypertensive

Randomized, controlled study of inhaled nitric oxide following surgery for congenital heart disease Read More »

Prevalence of variants in methylenetetrahydrofolate reductase and the severity of pulmonary vascular disease

Ronald W. Day, Gordon K. Mack, Andrea M. Barker, Tiffany Q. Rees, Lynda O. Jorgensen, Lorenzo D. BottoUniversity of Utah and Primary Children’s HospitalUnited States Pediatric CardiologyPediatr Cardiol 2015; 36: 524-530DOI: 10.1007/s00246-014-1044-x AbstractPulmonary hypertension is a serious disease associated with constriction, cellular proliferation, inflammation, and in situ thrombosis of the small vessels of the lung. Some

Prevalence of variants in methylenetetrahydrofolate reductase and the severity of pulmonary vascular disease Read More »

Improving guidance for the correctability of congenital shunts with increased pulmonary vascular resistance

Ronald W. DayUniversity of Utah and Primary Children’s HospitalUnited States International Journal of Cardiology Congenital Heart DefectsInt J Cardiol Congenit Heart Dis 2021;doi.org/10.1016/j.ijcchd.2021.100184 AbstractBackground. Based upon expert opinion, guidelines have been proposed for the correctability of congenital cardiovascular shunts with increased pulmonary vascular resistance. This study reports the accuracy of published guidelines using a dataset

Improving guidance for the correctability of congenital shunts with increased pulmonary vascular resistance Read More »

Scroll to Top